Weighted Average Number of Shares Outstanding, Basic of ELITE PHARMACEUTICALS INC /NV/ from 30 Sep 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
ELITE PHARMACEUTICALS INC /NV/ quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 30 Sep 2010 to 31 Dec 2025.
  • ELITE PHARMACEUTICALS INC /NV/ Weighted Average Number of Shares Outstanding, Basic for the quarter ending 31 Dec 2025 was 1,074,115,101, a 0.55% increase year-over-year.
  • ELITE PHARMACEUTICALS INC /NV/ annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 1,068,290,368, a 5.2% increase from 2023.
  • ELITE PHARMACEUTICALS INC /NV/ annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 1,015,443,363, a 0.25% increase from 2022.
  • ELITE PHARMACEUTICALS INC /NV/ annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 1,012,911,346, a 0.23% increase from 2021.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

ELITE PHARMACEUTICALS INC /NV/ Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 1,074,115,101 +5,841,993 +0.55% 01 Oct 2025 31 Dec 2025 10-Q 17 Feb 2026 2026 Q3
Q3 2025 1,071,897,174 +3,624,066 +0.34% 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025 2026 Q2
Q2 2025 1,068,363,108 +90,000 +0.01% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2026 Q1
Q1 2025 1,068,290,368 +52,847,005 +5.2% 01 Jan 2025 31 Mar 2025 10-K 30 Jun 2025 2025 FY
Q4 2024 1,068,273,108 +53,505,037 +5.3% 01 Oct 2024 31 Dec 2024 10-Q 17 Feb 2026 2026 Q3
Q3 2024 1,068,273,108 +54,358,027 +5.4% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025 2026 Q2
Q2 2024 1,068,273,108 +54,358,027 +5.4% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2026 Q1
Q1 2024 1,015,443,363 +2,532,017 +0.25% 01 Jan 2024 31 Mar 2024 10-K 30 Jun 2025 2025 FY
Q4 2023 1,014,768,071 +852,990 +0.08% 01 Oct 2023 31 Dec 2023 10-Q 13 Feb 2025 2025 Q3
Q3 2023 1,013,915,081 +1,686,825 +0.17% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024 2025 Q2
Q2 2023 1,013,915,081 +2,533,093 +0.25% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024 2025 Q1
Q1 2023 1,012,911,346 +2,303,633 +0.23% 01 Jan 2023 31 Mar 2023 10-K 01 Jul 2024 2024 FY
Q4 2022 1,013,915,081 +2,633,093 +0.26% 01 Oct 2022 31 Dec 2022 10-Q 14 Feb 2024 2024 Q3
Q3 2022 1,012,228,256 +946,268 +0.09% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023 2024 Q2
Q2 2022 1,011,381,988 +2,182,102 +0.22% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2024 Q1
Q1 2022 1,010,607,713 +67,609,838 +7.2% 01 Jan 2022 31 Mar 2022 10-K 29 Jun 2023 2023 FY
Q4 2021 1,011,281,988 +2,105,236 +0.21% 01 Oct 2021 31 Dec 2021 10-Q 14 Feb 2023 2023 Q3
Q3 2021 1,011,281,988 +97,737,328 +11% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2023 Q2
Q2 2021 1,009,199,886 +168,695,519 +20% 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022 2023 Q1
Q1 2021 942,997,875 +110,670,910 +13% 01 Jan 2021 31 Mar 2021 10-K 29 Jun 2022 2022 FY
Q4 2020 1,009,176,752 +179,782,549 +22% 01 Oct 2020 31 Dec 2020 10-Q 14 Feb 2022 2022 Q3
Q3 2020 913,544,660 +84,150,457 +10% 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021 2022 Q2
Q2 2020 840,504,367 +12,979,386 +1.6% 01 Apr 2020 30 Jun 2020 10-Q 16 Aug 2021 2022 Q1
Q1 2020 832,326,965 +18,154,074 +2.2% 01 Jan 2020 31 Mar 2020 10-K 14 Jun 2021 2021 FY
Q4 2019 829,394,203 +9,981,396 +1.2% 01 Oct 2019 31 Dec 2019 10-Q 16 Feb 2021 2021 Q3
Q3 2019 829,394,203 +17,138,197 +2.1% 01 Jul 2019 30 Sep 2019 10-Q 16 Nov 2020 2021 Q2
Q2 2019 827,524,981 +24,475,743 +3% 01 Apr 2019 30 Jun 2019 10-Q 14 Aug 2020 2021 Q1
Q1 2019 814,172,891 +18,103,472 +2.3% 01 Jan 2019 31 Mar 2019 10-K 29 Jun 2020 2020 FY
Q4 2018 819,412,807 +30,970,444 +3.9% 01 Oct 2018 31 Dec 2018 10-Q 10 Feb 2020 2020 Q3
Q3 2018 812,256,006 +29,831,382 +3.8% 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019 2020 Q2
Q2 2018 803,049,238 -16,272,083 -2% 01 Apr 2018 30 Jun 2018 10-Q 09 Aug 2019 2020 Q1
Q1 2018 796,069,419 -42,596,385 -5.1% 01 Jan 2018 31 Mar 2018 10-K 21 Jun 2019 2019 FY
Q4 2017 788,442,363 -116,320,814 -13% 01 Oct 2017 31 Dec 2017 10-Q 11 Feb 2019 2019 Q3
Q3 2017 782,424,624 -24,443,867 -3% 01 Jul 2017 30 Sep 2017 10-Q 09 Nov 2018 2019 Q2
Q2 2017 819,321,321 +96,537,879 +13% 01 Apr 2017 30 Jun 2017 10-Q 09 Aug 2018 2019 Q1
Q1 2017 838,665,804 +164,760,319 +24% 01 Jan 2017 31 Mar 2017 10-K 14 Jun 2018 2018 FY
Q4 2016 904,763,177 +219,989,348 +32% 01 Oct 2016 31 Dec 2016 10-Q 09 Feb 2018 2018 Q3
Q3 2016 806,868,491 +141,538,060 +21% 01 Jul 2016 30 Sep 2016 10-Q 09 Nov 2017 2018 Q2
Q2 2016 722,783,442 +75,931,899 +12% 01 Apr 2016 30 Jun 2016 10-Q 09 Aug 2017 2018 Q1
Q1 2016 673,905,485 +82,690,526 +14% 01 Jan 2016 31 Mar 2016 10-K 14 Jun 2018 2018 FY
Q4 2015 684,773,829 +83,664,121 +14% 01 Oct 2015 31 Dec 2015 10-Q 09 Feb 2017 2017 Q3
Q3 2015 665,330,431 +87,639,139 +15% 01 Jul 2015 30 Sep 2015 10-Q 09 Nov 2016 2017 Q2
Q2 2015 646,851,543 +81,701,312 +14% 01 Apr 2015 30 Jun 2015 10-Q 09 Aug 2016 2017 Q1
Q1 2015 591,214,959 +128,192,968 +28% 01 Jan 2015 31 Mar 2015 10-K 14 Jun 2017 2017 FY
Q4 2014 601,109,708 +92,470,892 +18% 01 Oct 2014 31 Dec 2014 10-Q 09 Feb 2016 2016 Q3
Q3 2014 577,691,292 +155,699,638 +37% 01 Jul 2014 30 Sep 2014 10-Q 30 Dec 2015 2016 Q2
Q2 2014 565,150,231 +177,180,250 +46% 01 Apr 2014 30 Jun 2014 10-Q 30 Dec 2015 2016 Q1
Q1 2014 463,021,991 +113,946,349 +33% 01 Jan 2014 31 Mar 2014 10-K 15 Jun 2016 2016 FY
Q4 2013 508,638,816 +158,418,592 +45% 01 Oct 2013 31 Dec 2013 10-Q 17 Feb 2015 2015 Q3
Q3 2013 421,991,654 +73,692,847 +21% 01 Jul 2013 30 Sep 2013 10-Q 14 Nov 2014 2015 Q2
Q2 2013 387,969,981 +50,697,759 +15% 01 Apr 2013 30 Jun 2013 10-Q 14 Aug 2014 2015 Q1
Q1 2013 349,075,642 +89,912,363 +35% 01 Jan 2013 31 Mar 2013 10-K 30 Jun 2014 2014 FY
Q4 2012 350,220,224 +88,152,877 +34% 01 Oct 2012 31 Dec 2012 10-Q 14 Feb 2014 2013 Q3
Q3 2012 348,298,807 +100,051,554 +40% 01 Jul 2012 30 Sep 2012 10-Q 14 Nov 2013 2013 Q2
Q2 2012 337,272,222 +105,268,725 +45% 01 Apr 2012 30 Jun 2012 10-Q 14 Aug 2013 2013 Q1
Q1 2012 259,163,279 01 Jan 2012 31 Mar 2012 10-K 21 Jun 2013 2012 FY
Q4 2011 262,067,347 -96,611,455,653 -100% 01 Oct 2011 31 Dec 2011 10-Q 14 Feb 2013 2012 Q3
Q3 2011 248,247,253 +155,879,573 +169% 01 Jul 2011 30 Sep 2011 10-Q 14 Nov 2012 2012 Q2
Q2 2011 232,003,497 01 Apr 2011 30 Jun 2011 10-Q 14 Aug 2012 2012 Q1
Q4 2010 96,873,523,000 01 Oct 2010 31 Dec 2010 10-Q 14 Feb 2012 2011 Q3
Q3 2010 92,367,680 01 Jul 2010 30 Sep 2010 10-Q 14 Nov 2011 2011 Q2

ELITE PHARMACEUTICALS INC /NV/ Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 1,068,290,368 +52,847,005 +5.2% 01 Apr 2024 31 Mar 2025 10-K 30 Jun 2025 2025 FY
2023 1,015,443,363 +2,532,017 +0.25% 01 Apr 2023 31 Mar 2024 10-K 30 Jun 2025 2025 FY
2022 1,012,911,346 +2,303,633 +0.23% 01 Apr 2022 31 Mar 2023 10-K 01 Jul 2024 2024 FY
2021 1,010,607,713 +67,609,838 +7.2% 01 Apr 2021 31 Mar 2022 10-K 29 Jun 2023 2023 FY
2020 942,997,875 +110,670,910 +13% 01 Apr 2020 31 Mar 2021 10-K 29 Jun 2022 2022 FY
2019 832,326,965 +18,154,074 +2.2% 01 Apr 2019 31 Mar 2020 10-K 14 Jun 2021 2021 FY
2018 814,172,891 +18,103,472 +2.3% 01 Apr 2018 31 Mar 2019 10-K 29 Jun 2020 2020 FY
2017 796,069,419 -42,596,385 -5.1% 01 Apr 2017 31 Mar 2018 10-K 21 Jun 2019 2019 FY
2016 838,665,804 +164,760,319 +24% 01 Apr 2016 31 Mar 2017 10-K 14 Jun 2018 2018 FY
2015 673,905,485 +82,690,526 +14% 01 Apr 2015 31 Mar 2016 10-K 14 Jun 2018 2018 FY
2014 591,214,959 +128,192,968 +28% 01 Apr 2014 31 Mar 2015 10-K 14 Jun 2017 2017 FY
2013 463,021,991 +113,946,349 +33% 01 Apr 2013 31 Mar 2014 10-K 15 Jun 2016 2016 FY
2012 349,075,642 +89,912,363 +35% 01 Apr 2012 31 Mar 2013 10-K 30 Jun 2014 2014 FY
2011 259,163,279 01 Apr 2011 31 Mar 2012 10-K 21 Jun 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.